MoneyWorks4Me

RPG Life Sciences - Quaterly Results

18 Oct 2023 Evaluate
The revenue for the September 2023 quarter is pegged at Rs. 1535.80 millions, about 13.94% up against Rs. 1347.90 millions recorded during the year-ago period.Net Profit recorded in the quarter ended September 2023 rise to 29.49% to Rs. 258.60  millions  compared to R. 199.70 millions in corresponding previous quarter.Operating profit surged to 391.20 millions from the corresponding previous quarter of 309.60 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 1535.80 1347.90 13.94 3013.60 2637.20 14.27 5128.10 4401.60 16.51
Other Income 18.30 12.30 48.78 36.40 24.50 48.57 48.00 29.90 60.54
PBIDT 391.20 309.60 26.36 731.70 600.20 21.91 1074.90 893.50 20.30
Interest 1.00 0.80 25.00 1.70 1.90 -10.53 3.10 5.20 -40.38
PBDT 390.20 308.80 26.36 730.00 598.30 22.01 1071.80 888.30 20.66
Depreciation 42.30 38.70 9.30 84.40 77.00 9.61 155.00 156.60 -1.02
PBT 347.90 270.10 28.80 645.60 521.30 23.84 916.80 731.70 25.30
TAX 89.30 70.40 26.85 166.00 139.50 19.00 240.40 216.90 10.83
Deferred Tax -7.40 -1.20 516.67 -9.90 2.10 -571.43 -3.10 -10.70 -71.03
PAT 258.60 199.70 29.49 479.60 381.80 25.62 676.40 514.80 31.39
Equity 132.30 132.30 0.00 132.30 132.30 0.00 132.30 132.30 0.00
PBIDTM(%) 25.47 22.97 10.90 24.28 22.76 6.68 20.96 20.30 3.26
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..